DUSP1 and cancer: As most cancers are treated using a combination of chemotherapy, radiation, and/or immunotherapy, when evaluating DUSP1 as a therapeutic target, it will be critical to examine the interactions between these current oncologic approaches and DUSP1 inhibition.